Do not use this medication if you or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Novo Nordisk's zenagamtide showed 14.6% weight loss in adults with type 2 diabetes in a mid-stage study
Adverse reactions to drugs BNF / NICE
Song, G., Yang, D., Wang, Y., de Graaf, C., Zhou, Q., Jiang, S., Liu, K., Cai, X., Dai, A., Lin, G., Liu, D., Wu, F., Wu, Y., Zhao, S., Ye, L., Han, G.W., Lau, J., Wu, B., Hanson, M.A., Liu, Z.J., Wang, M.W., Stevens, R.C
Jackson, E
The combination of its strong albumin binding and long half-life creates conditions for sustained receptor stimulation in salivary glands